SC Orders BCI Probe After Party Denies Engaging Advocates in Fraudulent Settlement Case  ||  SC Orders District-Wise Survey to Ensure POSH Act Compliance by Employers  ||  NCLT: No Sale of Assets Below 25% Reserve Price Cut Under Liquidation Regulations  ||  SC Bars Action Against 10-Yr Diesel & 15-Yr Petrol Vehicle Owners in Delhi NCR  ||  SC: Convict Completing Fixed-Term Life Sentence Can Be Freed Without Seeking Remission  ||  SC Appoints Justice Nageswara Rao as Ombudsman of Bihar Cricket Association  ||  SC Seeks NHRC, NCW, NCPCR Replies on Pleas Against Islamic Divorce Practice 'Talaq-e-Hasan'  ||  SC Seeks NHRC, NCW, NCPCR Replies on Pleas Against Islamic Divorce Practice 'Talaq-e-Hasan'  ||  Delhi HC: Income Tax Evasion Complaint Not Premature Despite Pending Reassessment  ||  Patna HC:Before Harshest Punishment, Authority Must Consider Officer’s Reply    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved